Neuroblastoma: The basis for cure in limited‐resource settings
- 2 February 2021
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (7) , e28923
Abstract
Background: Neuroblastoma (NB) contributes the most to the mortality of childhood malignancies worldwide. The disease spectrum is heterogenous and the management complex and costly, especially in advanced disease or disease with adverse biology. In low‐ and middle‐income countries (LMICs) the majority of NB presents in advanced stages. Therefore, with limited resources and poor prognosis the treatment of NB is often not a priority. The aim of the study was to evaluate the research activities and perceptions of the management of NB that determine the research and treatment approaches in LMICs.Methods: Data were sourced from https://www.clinicaltrials.gov/ identifying NB trials open to LMIC. Abstracts on NB research presented at the International Society for Paediatric Oncology (SIOP) Congresses between 2014 and 2020 were evaluated according to income status. An online survey evaluating medical views on NB in LMICs and the effect on the management was conducted. Descriptive analysis was done. Where appropriate categorical association between covariates was assessed using the Pearson chi‐square (χ2) test or Fishers exact test.Results: There were 15/562 (2.7%) trials open to LMIC. Only six of 138 (4.3%) LMIC participated in NB trials. Of the 688 abstracts presented between 2014 and 2020 at the SIOP International Congress on NB as primary subject, 297 (42.7%) were from LMICs. Only two were from low‐income countries (LICs). Sixty‐one countries responded to the NB survey. Positive views towards NB management were present when treatment was based on a national protocol, the availability of trimodal or advanced treatment options were present, and when a balance of metastatic or local disease were treated.Conclusion: Management of NB in LMICs should include increased advocacy and research as well as implementation of national management strategies.Keywords
This publication has 23 references indexed in Scilit:
- Childhood Neuroblastoma: Incidence and Survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA Network 2000-2012Pediatric Blood & Cancer, 2016
- Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with NeuroblastomaKlinische Padiatrie, 2016
- Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global ChallengeJournal of Clinical Oncology, 2015
- SIOP‐PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low‐ and middle‐income settingsPediatric Blood & Cancer, 2015
- Redesigning Primary Care to Tackle the Global Epidemic of Noncommunicable DiseaseAmerican Journal of Public Health, 2015
- Cancer care delivery in India at the grassroot level: Improve outcomesIndian Journal of Medical and Paediatric Oncology, 2014
- Neuroblastoma: A Review of Management and OutcomeIndian Journal of Pediatrics, 2012
- The epidemiology of neuroblastoma: a reviewPaediatric and Perinatal Epidemiology, 2009
- Treatment of B‐cell lymphoma with LMB modified protocols in Africa—report of the French‐African Pediatric Oncology Group (GFAOP)Pediatric Blood & Cancer, 2008
- Neuroblastoma: biological insights into a clinical enigmaNature Reviews Cancer, 2003